Minden M - Search Results

1

Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.

Leyton JV, Hu M, Gao C, Turner PV, Dick JE, Minden M, Reilly RM. Leyton JV, et al. Among authors: minden m. J Nucl Med. 2011 Sep;52(9):1465-73. doi: 10.2967/jnumed.111.087668. Epub 2011 Aug 4. J Nucl Med. 2011. PMID: 21816968 Free article.

2

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. Lapidot T, et al. Among authors: minden m. Nature. 1994 Feb 17;367(6464):645-8. doi: 10.1038/367645a0. Nature. 1994. PMID: 7509044

3

Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.

Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE. Sirard C, et al. Among authors: minden m. Blood. 1996 Feb 15;87(4):1539-48. Blood. 1996. PMID: 8608245 Free article.

4

Acute leukemia in adults.

Minden M, Imrie K, Keating A. Minden M, et al. Curr Opin Hematol. 1996 Jul;3(4):259-65. doi: 10.1097/00062752-199603040-00003. Curr Opin Hematol. 1996. PMID: 9372086 Review.

5

High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE. Wang JC, et al. Among authors: minden m. Blood. 1998 Apr 1;91(7):2406-14. Blood. 1998. PMID: 9516140 Free article.

6

Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Dorrell C, Takenaka K, Minden MD, Hawley RG, Dick JE. Dorrell C, et al. Mol Cell Biol. 2004 Aug;24(16):6993-7002. doi: 10.1128/MCB.24.16.6993-7002.2004. Mol Cell Biol. 2004. PMID: 15282300 Free PMC article.

7

Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.

Meng YS, Khoury H, Dick JE, Minden MD. Meng YS, et al. Among authors: minden md. Leukemia. 2005 Nov;19(11):1941-7. doi: 10.1038/sj.leu.2403836. Leukemia. 2005. PMID: 16094422

8

Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.

Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly RM. Chen P, et al. Among authors: minden m. J Nucl Med. 2006 May;47(5):827-36. J Nucl Med. 2006. PMID: 16644753 Free article.

9

Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.

Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM. Kersemans V, et al. Among authors: minden md. J Nucl Med. 2008 Sep;49(9):1546-54. doi: 10.2967/jnumed.107.047399. Epub 2008 Aug 14. J Nucl Med. 2008. PMID: 18703602 Free article.

10

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, Ma J, Minden MD, Downing JR, Dick JE. Notta F, et al. Nature. 2011 Jan 20;469(7330):362-7. doi: 10.1038/nature09733. Nature. 2011. PMID: 21248843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters